Heliospectra AB (publ) (OTCQB: HLSPY, FIRSTNORTH: HELIO), a world leader in intelligent lighting technology for greenhouses and controlled farming environments, announces an order from a value-added reseller for a customer building a high-performance medicinal cannabis cultivation facility in Eastern Canada. The order for the Heliospectra LX60 intelligent LED lighting solution is valued at SEK 5,488,411 (USD $651,200).
Heliospectra’s industry-leading LED grow lights and software control enable commercial growers to accelerate harvest and production cycles while delivering consistent yields and highest-quality crops year-round. The ability to customize advanced light strategies, intensities and spectra across the plant growth cycle will also create clear business advantages as Canadian licensed cannabis cultivation teams strive to bring more specialized, proprietary medical products to market faster.
“Heliospectra LEDs are quickly displacing traditional HID and HPS lamps in Canada as growers leave the limitations and high maintenance costs of these fixtures behind,” said Ali Ahmadian, CEO of Heliospectra. “Today’s commercial growers who are working with food crops, flowers or medicinal plants recognize that Heliospectra’s LED lighting and dynamic, real-time light control software will cost-effectively scale business performance and increase yields.”
The order will be shipped during the first quarter of 2018.
Ali Ahmadian, CEO of Heliospectra | +46 (0)72 203 6344 | [email protected]
Redeye is Heliospectra Certified Advisor for Nasdaq First North - www.redeye.se
Heliospectra AB (publ) (OTCQB: HLS, FIRST NORTH: HELIO) is the industry’s most proven intelligent lighting technology for greenhouse and controlled plant growth environments. With the vision to make commercial crop production more connected and resource-efficient, growers and commercial producers across six continents use Heliospectra holistic and flexible solutions to consistently increase yields while producing crops that achieve quality appearance, superior nutritional or medicinal value and longer shelf life, harvest after harvest. Founded in 2006 and winner of multiple international awards and recognitions, Heliospectra has raised more than $32 million in capital to date. As a publicly traded company, the majority ownership remains with some of Heliospectra earliest investors Weland Steel, Swedish Industrial Fund and Midroc New Technology. For more information, please visit https://www.heliospectra.com.
The statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not take any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.
This information is information that Heliospectra AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 14.00 CEST / 8 AM EDT on January 3, 2018.